CRF TCT 2022 Poster

TCT 2022 Poster

Goldberg S et al.
2022

Baseline data

CRF TCT 2022 Poster
CRF TCT 2022 Poster
CRF TCT 2022 Poster

Survival

Looking into recently published survival with GDMT over 2 years, patients with a Carillon Mitral Contour System are doing as well as not having moderate/severe regurgitation. In comparison to other available treatment, the data indicated at least a similar outcome over 2 years.
CRF TCT 2022 Poster
CRF TCT 2022 Poster